Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
1. Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance
- Luis Menéndez-Arias
- Mar Álvarez
- Beatriz Pacheco
2. Substitutions of rtL228 and/or L229 are involved in the regulation of replication and HBsAg secretion in hepatitis B virus, and do not affect susceptibility to nucleos(t)ide analogs
- Bo Qin
- Yechao Zhou
- Guozhong Zhou
- Xiuping Xu
- Yanan Wang
- Jinkun Chen
3. Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors
- Mousumi Khatun
- Krishna Kumar
- Ayana Baidya
- Rajiv Kumar Mondal
- Ondřej Baszczyňski
- Filip Kalčic
- Soma Banerjee
- Gopal Krishna Dhali
- Kausik Das
- Abhijit Chowdhury
- Zlatko Janeba
- Saikat Chakrabarti
- Simanti Datta
- J.-H. James Ou
4. Whole genome analysis of hepatitis B virus before and during long-term therapy in chronic infected patients: Molecular characterization, impact on treatment and liver disease progression
- Zeineb Belaiba
- Kaouther Ayouni
- Mariem Gdoura
- Wafa Kammoun Rebai
- Henda Touzi
- Amel Sadraoui
- Walid Hammemi
- Lamia Yacoubi
- Salwa Abdelati
- Lamine Hamzaoui
- Mohamed Msaddak Azzouz
- Anissa Chouikha
- Henda Triki
5. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining
- Xizhan Xu
- Kuanhui Xiang
- Mingze Su
- Yao Li
- Wei Ji
- Yutang Li
- Hui Zhuang
- Tong Li